Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

FHS
May 20, 2024
10:56 am

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

Neumora shares sink following Phase III flop in MDD – Pharmaceutical Technology

Neumora’s share price plummeted after the company shared news on a Phase III trial failure for its lead candidate. Credit: Ground Picture via Shutterstock Neumora

January 4, 2025

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech intends to advance a prophylactic mRNA-based Mpox vaccine with an encouraging safety profile that can be produced at scale. Credit: Marcus Krauss/Shutterstock.com. BioNTech has

September 19, 2023

Xcovery nabs first FDA approval for lung cancer drug

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.